Delayed
Singapore S.E.
23:59:32 2024-05-07 EDT
|
5-day change
|
1st Jan Change
|
3.61
SGD
|
+2.27%
|
|
+1.12%
|
-1.63%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,009
|
2,341
|
3,104
|
2,275
|
2,220
|
2,136
|
-
|
-
|
Enterprise Value (EV)
1 |
2,727
|
3,110
|
3,906
|
2,275
|
2,220
|
2,927
|
3,013
|
2,136
|
P/E ratio
|
16.3
x
|
26.8
x
|
9.35
x
|
55.3
x
|
-
|
19.9
x
|
19.8
x
|
19.6
x
|
Yield
|
3.97%
|
3.56%
|
2.74%
|
3.82%
|
4.02%
|
4.17%
|
4.24%
|
4.91%
|
Capitalization / Revenue
|
17.4
x
|
19.4
x
|
25.7
x
|
17.5
x
|
15.1
x
|
14.2
x
|
13.9
x
|
13.7
x
|
EV / Revenue
|
23.7
x
|
25.7
x
|
32.4
x
|
17.5
x
|
15.1
x
|
19.4
x
|
19.6
x
|
13.7
x
|
EV / EBITDA
|
29.2
x
|
32.4
x
|
41.1
x
|
21.7
x
|
18.3
x
|
23.8
x
|
24
x
|
16.6
x
|
EV / FCF
|
34.2
x
|
50.4
x
|
263
x
|
-74.5
x
|
-
|
148
x
|
116
x
|
30.3
x
|
FCF Yield
|
2.92%
|
1.98%
|
0.38%
|
-1.34%
|
-
|
0.68%
|
0.86%
|
3.3%
|
Price to Book
|
1.7
x
|
1.98
x
|
2.16
x
|
1.61
x
|
-
|
1.48
x
|
1.46
x
|
1.24
x
|
Nbr of stocks (in thousands)
|
605,002
|
605,002
|
605,002
|
605,002
|
605,002
|
605,002
|
-
|
-
|
Reference price
2 |
3.320
|
3.870
|
5.130
|
3.760
|
3.670
|
3.530
|
3.530
|
3.530
|
Announcement Date
|
20-01-21
|
21-01-25
|
22-01-24
|
23-01-27
|
24-02-01
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
115.2
|
120.9
|
120.7
|
130
|
147.5
|
150.8
|
153.6
|
155.6
|
EBITDA
1 |
93.27
|
96.14
|
95.01
|
104.8
|
121.6
|
122.8
|
125.4
|
128.3
|
EBIT
1 |
93.27
|
96.14
|
95.01
|
104.8
|
121.6
|
121
|
123.7
|
128.3
|
Operating Margin
|
80.95%
|
79.53%
|
78.71%
|
80.63%
|
82.45%
|
80.25%
|
80.52%
|
82.47%
|
Earnings before Tax (EBT)
1 |
132
|
96.39
|
340.8
|
48.22
|
108.3
|
110.6
|
137.8
|
143
|
Net income
1 |
123.4
|
87.22
|
331.9
|
41.14
|
100.5
|
106.6
|
142.4
|
149.6
|
Net margin
|
107.09%
|
72.15%
|
274.95%
|
31.65%
|
68.13%
|
70.7%
|
92.67%
|
96.09%
|
EPS
2 |
0.2040
|
0.1442
|
0.5486
|
0.0680
|
-
|
0.1773
|
0.1785
|
0.1800
|
Free Cash Flow
1 |
79.62
|
61.74
|
14.87
|
-30.55
|
-
|
19.8
|
25.9
|
70.4
|
FCF margin
|
69.1%
|
51.07%
|
12.32%
|
-23.51%
|
-
|
13.13%
|
16.86%
|
45.24%
|
FCF Conversion (EBITDA)
|
85.36%
|
64.21%
|
15.66%
|
-
|
-
|
16.12%
|
20.65%
|
54.85%
|
FCF Conversion (Net income)
|
64.52%
|
70.78%
|
4.48%
|
-
|
-
|
18.57%
|
18.19%
|
47.07%
|
Dividend per Share
2 |
0.1319
|
0.1379
|
0.1408
|
0.1438
|
0.1477
|
0.1471
|
0.1498
|
0.1734
|
Announcement Date
|
20-01-21
|
21-01-25
|
22-01-24
|
23-01-27
|
24-02-01
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
718
|
769
|
802
|
-
|
-
|
791
|
877
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
7.7
x
|
7.997
x
|
8.445
x
|
-
|
-
|
6.442
x
|
6.991
x
|
-
|
Free Cash Flow
1 |
79.6
|
61.7
|
14.9
|
-30.6
|
-
|
19.8
|
25.9
|
70.4
|
ROE (net income / shareholders' equity)
|
10.6%
|
7.37%
|
25.4%
|
2.89%
|
7.11%
|
7.14%
|
8.8%
|
8.69%
|
ROA (Net income/ Total Assets)
|
6.33%
|
4.29%
|
15%
|
1.76%
|
-
|
4.49%
|
5.79%
|
5.79%
|
Assets
1 |
1,949
|
2,035
|
2,206
|
2,344
|
-
|
2,377
|
2,460
|
2,583
|
Book Value Per Share
2 |
1.950
|
1.960
|
2.370
|
2.330
|
-
|
2.390
|
2.410
|
2.840
|
Cash Flow per Share
2 |
0.1500
|
0.1500
|
0.1500
|
-
|
-
|
0.1900
|
0.1800
|
-
|
Capex
1 |
9.63
|
4.58
|
11.7
|
17.7
|
-
|
78.4
|
93.9
|
56.8
|
Capex / Sales
|
8.36%
|
3.79%
|
9.69%
|
13.59%
|
-
|
51.98%
|
61.12%
|
36.5%
|
Announcement Date
|
20-01-21
|
21-01-25
|
22-01-24
|
23-01-27
|
24-02-01
|
-
|
-
|
-
|
Last Close Price
3.53
SGD Average target price
4.42
SGD Spread / Average Target +25.21% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.63% | 1.58B | | +8.08% | 58.27B | | -5.44% | 19.08B | | -3.03% | 13.51B | | +0.88% | 7.64B | | -13.64% | 5.88B | | +11.17% | 3.53B | | +3.29% | 3.41B | | -0.16% | 3.26B | | +17.55% | 2.85B |
Healthcare REITs
|